In this workshop, participants will be introduced to experiments and techniques used in the upstream and downstream processes for monoclonal antibody production using NISTCHO cells. Two approaches will be taken; a low-tech approach for cell growth and mAb purification, and a high-tech approach using process-controlled bioreactors for cell growth and AKTA FPLC systems for protein purification. Biochemical QC techniques for determining purity, and titer will also be covered. Discussions and presentations will cover approaches to incorporating this material into courses and programs and examples ...
Listen in to The Antibody Society's December 4, 2025 webinar featuring Dr. Paul Carter as he covers the history of monoclonal technologies from the first hybridomas in 1975 to the more than 200 approved antibody therapeutics that are saving the lives of millions of patients. Note: the audio is a ...
Description: NISTCHO cells are a newly released recombinant cell line that produce cNISTmAb, an industry relevant, open access monoclonal antibody to RSV. The NISTCHO cell line was developed by the National Institute of Standards and Technology (NIST) and MilliporeSigma and is available as a ...
